Corcept Therapeutics
Price & Volume
Stats
See more52W Range | $28.66-$91 |
Market Cap | $6.4B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $769M |
Revenue Growth (YoY) | 4.9% |
Gross Profit (12 Mos) | $755.6M |
Diluted EPS | $0.35 |
News
See moreYahoo Finance • 12 days ago
S&P 500 and Nasdaq 100 Post New Record Highs on Chip Stock Strength
Yahoo Finance • 12 days ago
Chip Stock Strength Lifts the Broader Market
Yahoo Finance • 12 days ago
Stocks Pressured by Signs of Resurgent Inflation
Yahoo Finance • 23 days ago
Corcept (CORT) Upgraded After Key Regulatory Approval for Lifyorli
About
CEO | Dr. Joseph K. Belanoff M.D. |
CFO | Mr. Atabak Mokari |
Address | 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 730 |